Overview
Investcare is a pharmaceutical group that includes MEDI&MORE, a wholesaler serving over 3,000 pharmacies with more than 20,000 products, and the 4 Pory Roku partner pharmacy chain, with 240 locations across 16 provinces in Poland. Its medicare.pl portal covers health and beauty and enables prescription reservations and free delivery. Group company Biocanto produces and distributes dietary supplements and medical products.
Financials
Revenue history (in k)
From the notes
| Profit allocation | Retained in reserve capital | |
| Revenue structure | Usługi IT, HR, PR, obsługi prawnej i controllingu | |
| Management board pay | $23,606 | |
| Merger or transformation | Yes | |
| Shareholders |
| |
| Shares in other companies |
|
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 49 days for 2025). All were audited by a statutory auditor.
- 202502/09/2026
- 202401/07/2025
- 202308/07/2024
- 202203/07/2023
- 202125/08/2022
- 202027/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News
Industry
Offer
- Pharmaceutical wholesale
- Medicines and pharmacy products
- Pharmacy retail
- Online medicine reservations
- Dietary supplements
- Medical devices
- Accounting and HR services
Websites
- grupainvestcare.plInvestcare Grupa Farmaceutyczna – MEDI&MORE | Medicare.pl | Sieć 4 Pory RokuWordPress 6.9ElementorGoogle AnalyticsGoogle Tag ManagerLLiteSpeed
Job offers
The company has its own careers page: grupainvestcare.pl/kariera-praca-staze.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the company is represented by a member of the management board independently or by two commercial proxies jointly. In the case of a multi-member management board, the company is represented by two members of the management board jointly or by one member of the management board jointly with a commercial proxy or by two commercial proxies jointly.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Allecco sp. z o.o. | 1,164,222.04 USD | 99.9988% | ||
Biocanto sp. z o.o. | 55,361.97 USD | 99.9756% | ||
Mediqmedia sp. z o.o. | 13,492.71 USD | 99.9% |
Capital group
The company is the parent company of a corporate group.
| Name | Country |
|---|---|
| Pharmacy Solutions |
Bank accounts
Registered as a VAT taxpayer on 2018-07-14.
09 1140 1049 0000 3409 1300 1002
36 1140 1049 0000 3409 1300 1001
11 1050 1214 1000 0090 3159 9294
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 159.8KPLN 159,846 |
Investment property | PLN 122.3KPLN 122,275 |
MSiG notices
6 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| Mar 6, 2025 | Shareholders' meeting convened | |
| Oct 8, 2024 | Shareholders' meeting convened | |
| Jun 12, 2024 | Shareholders' meeting convened | |
| Apr 10, 2024 | Shareholders' meeting convened | |
| Oct 3, 2023 | Shareholders' meeting convened |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-Kielce S.A. | $13,590,657.96 | farmacol.com.pl | ||
| Interpharma sp. z o.o. | $12,321,125.25 | interpharma.com.pl | ||
| Trumedico Pl sp. z o.o. + limited partnership | $11,405,243.37 | trumedico.pl | ||
| Vipado sp. z o.o. | $11,385,128.54 | vipado.pl | ||
| Synergy Trading sp. z o.o. | $3,055,373.51 | synergytrading.com.pl | ||
| Solinea Pharma sp. z o.o. | $1,000,645.63 | solinea.pl | ||
| Kleemed Pharmaceuticals Poland sp. z o.o. | $847,166.12 | kleemed.com.pl | ||
| Sincofarm sp. z o.o. | $407,150.59 | sincofarm.pl | ||
| Bonopharm sp. z o.o. | $405,123.74 | bonopharm.com | ||
| Biocanto Pharma sp. z o.o. | $186,097.96 | biocanto.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-12-09 | Share capital increase (750,000.00 PLN → 1,420,000.00 PLN) | |
| 2019-07-01 | Share capital increase (250,000.00 PLN → 750,000.00 PLN) | |
| 2018-05-30 | Entered in the register |
FAQ
Last updated: 2026-10-07





